Novel approaches to food allergy

Clinical Reviews in Allergy and Immunology

Volumn 46, Issue 3, 2014, Pages 250-257

  Yang, Yao Hsu ^a   Chiang, Bor Luen ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Biologics; Food allergy; Immunotherapy; Pharmaceuticals

Indexed keywords

ALLERGEN; CHINESE DRUG; IMMUNOGLOBULIN E ANTIBODY; MEPOLIZUMAB; ANTI-IGE ANTIBODIES; ANTIIDIOTYPIC ANTIBODY; HERBACEOUS AGENT; IL5 PROTEIN, HUMAN; IMMUNOGLOBULIN E; INTERLEUKIN 5; MONOCLONAL ANTIBODY;

ALLERGIC DISEASE; ANAPHYLAXIS; ARTICLE; CHINESE MEDICINE; CLINICAL STUDY; DRUG EFFICACY; DRUG SAFETY; EPICUTANEOUS IMMUNOTHERAPY; FOOD ALLERGY; HERBAL MEDICINE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; ORAL IMMUNOTHERAPY; PEANUT ALLERGY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; BLOOD; CHEMISTRY; DESENSITIZATION; DRUG ADMINISTRATION ROUTE; FOOD HYPERSENSITIVITY; FRUIT; IMMUNOLOGY; PATHOLOGY; PROCEDURES; VEGETABLE;

ALLERGENS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED; DESENSITIZATION, IMMUNOLOGIC; DRUG ADMINISTRATION ROUTES; DRUGS, CHINESE HERBAL; FOOD HYPERSENSITIVITY; FRUIT; HUMANS; IMMUNOGLOBULIN E; IMMUNOTHERAPY; INTERLEUKIN-5; VEGETABLES;

EID: 84902551271     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-013-8354-2     Document Type: Article

References (56)

1. Sicherer SH (2011) Epidemiology of food allergy. J Allergy Clin Immunol 127:594-602
2. Sicherer SH, Munoz-Furlong A, Godbold JH, Sampson HA (2010) US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol 125:1322-1326
3. Sicherer SH, Sampson HA (2010) Food allergy. J Allergy Clin Immunol 125:S116-S125
4. Wang J, Sampson HA (2011) Food allergy. J Clin Invest 121:827-835
5. Nowak-Wegrzyn A, Sampson HA (2011) Future therapies for food allergies. J Allergy Clin Immunol 127:558-573
6. Grimbaldeston MA, Metz M, Yu M, Tsai M, Galli SJ (2006) Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr Opin Immunol 18:751-760 (Pubitemid 44642318)
7. Gupta R, Sheikh A, Strachan DP, Anderson HR (2007) Time trends in allergic disorders in the UK. Thorax 62:91-96 (Pubitemid 46101772)
8. Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL et al (2008) The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 122:1161-1165
9. Scheinfeld N (2005) Omalizumab: a recombinant humanized monoclonal IgE-blocking antibody. Dermatol Online J 11:2
10. Leung DY, Sampson HA, Yunginger JW, Burks AW Jr, Schneider LC et al (2003) Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 348:986-993 (Pubitemid 36302243)
11. Sampson HA, Leung DY, Burks AW, Lack G, Bahna SL et al (2011) A phase II, randomized, double-blind, parallel group, placebo-controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J Allergy Clin Immunol 127:1309-1310
12. Rafi A, Do LT, Katz R, Sheinkopf LE, Simons CW et al (2010) Effects of omalizumab in patients with food allergy. Allergy Asthma Proc 31:76-83
13. Casale TB, Busse WW, Kline JN, Ballas ZK, Moss MH et al (2006) Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J Allergy Clin Immunol 117:134-140 (Pubitemid 43017150)
14. Kamin W, Kopp MV, Erdnuess F, Schauer U, Zielen S et al (2010) Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously. Pediatr Allergy Immunol 21:e160-e165
15. Stone KD, Prussin C (2008) Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases. Clin Exp Allergy 38:1858-1865
16. Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE et al (2004) Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 113:115-119 (Pubitemid 38096170)
17. Straumann A, Conus S, Grzonka P, Kita H, Kephart G et al (2010) Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut 59:21-30
18. Krishna MT, Huissoon AP (2011) Clinical immunology review series: an approach to desensitization. Clin Exp Immunol 163:131-146
19. Frew AJ (2010) Allergen immunotherapy. J Allergy Clin Immunol 125:S306-S313
20. Akdis CA, Akdis M (2011) Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 127:18-27
21. Oppenheimer JJ, Nelson HS, Bock SA, Christensen F, Leung DY (1992) Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 90:256-262
22. Nelson HS, Lahr J, Rule R, Bock A, Leung D (1997) Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 99:744-751 (Pubitemid 27280363)
23. Katelaris CH (2010) Food allergy and oral allergy or pollen-food syndrome. Curr Opin Allergy Clin Immunol 10:246-251
24. Asero R (1998) Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients. Clin Exp Allergy 28:1368-1373
25. Bucher X, Pichler WJ, Dahinden CA, Helbling A (2004) Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut. Allergy 59:1272-1276 (Pubitemid 39506725)
26. Kulis M, Vickery BP, Burks AW (2011) Pioneering immunotherapy for food allergy: clinical outcomes and modulation of the immune response. Immunol Res 49:216-226
27. Beyer K, Wahn U (2008) Oral immunotherapy for food allergy in children. Curr Opin Allergy Clin Immunol 8:553-556
28. Skripak JM, Nash SD, Rowley H, Brereton NH, Oh S et al (2008) A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol 122:1154-1160
29. Longo G, Barbi E, Berti I, Meneghetti R, Pittalis A (2008) Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol 121:343-347
30. Pajno GB, Caminiti L, Ruggeri P, De Luca R, Vita D (2010) Oral immunotherapy for cow's milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study. Ann Allergy Asthma Immunol 105:376-381
31. Buchanan AD, Green TD, Jones SM, Scurlock AM, Christie L (2007) Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 119:199-205 (Pubitemid 46037808)
32. Vickery BP, Pons L, Kulis M, Steele P, Jones SM (2010) Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance. Ann Allergy Asthma Immunol 105:444-450
33. Clark AT, Islam S, King Y, Deighton J, Anagnostou K (2009) Successful oral tolerance induction in severe peanut allergy. Allergy 64:1218-1220
34. Jones SM, Pons L, Roberts JL, Scurlock AM, Perry TTet al (2009) Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 124:292-300
35. Varshney P, Jones SM, Scurlock AM, Perry TT, Kemper A et al (2011) A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 127:654-660
36. Lin SY, Leatherman B (2011) Sublingual immunotherapy. Otolaryngol Clin North Am 44:753-764
37. Fernandez-Rivas M, Garrido Fernandez S, Nadal JA, Diaz de Durana MD, Garcia BE et al (2009) Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy 64:876-883
38. Enrique E, Pineda F, Malek T, Bartra J, Basagana M et al (2005) Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 116:1073-1079 (Pubitemid 41571791)
39. Kim EH, Bird JA, Kulis M, Laubach S, Pons L et al (2011) Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol 127:640-646
40. Kinaciyan T, Jahn-Schmid B, Radakovics A, Zwolfer B, Schreiber C et al (2007) Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1. J Allergy Clin Immunol 119:937-943 (Pubitemid 46527803)
41. Senti G, von Moos S, Kundig TM (2011) Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy? Allergy 66:798-809
42. Scurlock AM, Jones SM (2010) An update on immunotherapy for food allergy. Curr Opin Allergy Clin Immunol 10:587-593
43. Dupont C, Kalach N, Soulaines P, Legoue-Morillon S, Piloquet H et al (2010) Cow's milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol 125:1165-1167
44. Ferreira F, Briza P, Infuhr D, Schmidt G, Wallner M et al (2006) Modified recombinant allergens for safer immunotherapy. Inflamm Allergy Drug Targets 5:5-14 (Pubitemid 43796677)
45. Nowak-Wegrzyn A, Bloom KA, Sicherer SH, Shreffler WG, Noone S et al (2008) Tolerance to extensively heated milk in children with cow's milk allergy. J Allergy Clin Immunol 122:342-347
46. Lemon-Mule H, Sampson HA, Sicherer SH, Shreffler WG, Noone S et al (2008) Immunologic changes in children with egg allergy ingesting extensively heated egg. J Allergy Clin Immunol 122:977-983
47. Kim JS, Nowak-Wegrzyn A, Sicherer SH, Noone S, Moshier EL et al (2011) Dietary baked milk accelerates the resolution of cow's milk allergy in children. J Allergy Clin Immunol 128:125-131
48. Tanabe S (2007) Epitope peptides and immunotherapy. Curr Protein Pept Sci 8:109-118
49. Chuang YH, Yang YH, Wu SJ, Chiang BL (2009) Gene therapy for allergic diseases. Curr Gene Ther 9:185-191
50. Chua KY, Huangfu T, Liew LN (2006) DNAvaccines and allergic diseases. Clin Exp Pharmacol Physiol 33:546-550
51. Li XM, Srivastava K, Grishin A, Huang CK, Schofield B et al (2003) Persistent protective effect of heat-killed Escherichia coli producing "engineered," recombinant peanut proteins in a murine model of peanut allergy. J Allergy Clin Immunol 112:159-167 (Pubitemid 36819821)
52. DeLong JH, Simpson KH, Wambre E, James EA, Robinson D et al (2011) Ara h 1-reactive Tcells in individuals with peanut allergy. J Allergy Clin Immunol 127:1211-1218
53. Li X, Huang CK, Schofield BH, Burks AW, Bannon GA et al (1999) Strain-dependent induction of allergic sensitization caused by peanut allergen DNA immunization in mice. J Immunol 162:3045-3052 (Pubitemid 29309335)
54. Li XM, Zhang TF, Huang CK, Srivastava K, Teper AA et al (2001) Food Allergy Herbal Formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model. J Allergy Clin Immunol 108:639-646 (Pubitemid 32978039)
55. Srivastava KD, Kattan JD, Zou ZM, Li JH, Zhang L et al (2005) The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J Allergy Clin Immunol 115:171-178 (Pubitemid 40075439)
56. Wang J, Patil SP, Yang N, Ko J, Lee J et al (2010) Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study. Ann Allergy Asthma Immunol 105:75-84